Results 271 to 280 of about 2,599,480 (386)

Health Technology Assessment: Evaluation of Monoclonal Antibodies for the Treatment of Neuromyelitis Optica Spectrum Disorders. [PDF]

Drug Des Devel Ther
Wang C, Wu H, Huang Y, Liu A, Lai S.
europepmc   +1 more source

A Monoclonal Antibody Specific for the A Antigen of Brucella spp.

, 1984
R. Quinn, Alison Campbell, A.P. Phillips
openalex   +1 more source

Rapid Glass‐Substrate Digital Light 3D Printing Enables Anatomically Accurate Stroke Patient‐Specific Carotid Artery‐on‐Chips for Personalized Thrombosis Investigation

Advanced Materials, EarlyView.
A rapid glass‐substrate 3D microfabrication method creates anatomically accurate carotid artery‐on‐a‐chip models from stroke patient scans in 2 h. These miniaturized devices replicate patient‐specific blood vessel geometry and flow patterns, enabling real‐time imaging of clot formation under controlled injury.
Yunduo Charles Zhao, Zihao Wang, Arian Nasser, Allan Sun, Zhao Wang, Yingqi Zhang, Jianfang Ren, Haimei Zhao, Nicole Alexis Yap, Yinyan Wang, Zhiyong Li, Ken S Butcher, Freda Passam, Timothy Ang, Lining Arnold Ju   +14 more
wiley   +1 more source

Monoclonal Antibodies and Small-Molecule Therapies for Lichen Planus: Targeted Immunomodulation and Emerging Evidence. [PDF]

Antibodies (Basel)
Rosset F, Sciamarrelli N, Mastorino L, Pala V, Boskovic S, Bongiovanni E, Crespi O, Liao Y, Ribero S, Quaglino P.   +9 more
europepmc   +1 more source

Monoclonal antibodies used in solid-phase and liquid-phase assays, as exemplified by progesterone assay.

, 1987
Willfried Schramm, T Yang, A R Midgley
openalex   +1 more source

Advances and Strategies in Enhancing mRNA Cancer Vaccines

Advanced Materials, EarlyView.
Messenger RNA (mRNA) vaccines offer a powerful approach for cancer immunotherapy, but their clinical impact remains limited by delivery challenges and suboptimal immune activation. This review discusses key biological barriers and design strategies—including structural optimization, immunomodulation, organ targeting delivery, and advanced nanocarriers ...
Miao Zhang, Shengqi Chen, Haijun Hu, Yenhui Ong, Qianqian Ni   +4 more
wiley   +1 more source

Immune checkpoint inhibitors in cancer therapy: what lies beyond monoclonal antibodies? [PDF]

Med Oncol
Zamani MR, Šácha P.
europepmc   +1 more source

Artificial Intelligence‐Driven Nanoarchitectonics for Smart Targeted Drug Delivery

Advanced Materials, EarlyView.
This perspective introduces an artificial intelligence (AI)‐driven nanoarchitectonics framework for targeted drug delivery, combining database‐guided nanocarrier design, machine learning (ML)‐assisted surface engineering with a designed targeting system, and in silico modeling for dynamic optimization.
Hayeon Bae, Hyunsub Ji, Konstantin Konstantinov, Ronald Sluyter, Katsuhiko Ariga, Yong Ho Kim, Jung Ho Kim   +6 more
wiley   +1 more source

Generation of Conformation-Specific Monoclonal Antibodies for Integral Membrane Proteins. [PDF]

Curr Protoc
Sheldon N, Dhandapani G, Kim J, Spangler CJ, Fang C, Park J, Rao P, Gouaux E.   +7 more
europepmc   +1 more source

ACUTE CELLULAR REJECTION DURING EFFECTIVE EARLY PROPHYLACTIC OKT3 MONOCLONAL ANTIBODY TREATMENT AFTER RENAL TRANSPLANTATION

, 1989
NULL AUTHOR_ID
openalex   +1 more source